Quarry LP’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Sell
2,380
-10,938
-82% -$1.48M 0.03% 200
2026
Q1
$1.7M Buy
13,318
+310
+2% +$38.7K 0.31% 64
2025
Q4
$1.59M Sell
13,008
-16,430
-56% -$1.88M 0.25% 58
2025
Q3
$2.95M Buy
29,438
+23,438
+391% +$2.11M 0.65% 28
2025
Q2
$498K Buy
+6,000
New +$479K 0.11% 165

Other funds holding XBI

Quarry LP's XBI Position: Q2 2026 in Review

Quarry LP reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 82% in Q2 2026, selling an estimated $1.48M and leaving 2,380 shares worth $377K. The position accounts for 0.03% of the portfolio, ranked #200.

Quarry LP first reported a position in XBI in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.95M in Q3 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Quarry LP held 2,380 shares of State Street SPDR S&P Biotech ETF worth $377K as of Q2 2026.
  • Quarry LP sold 10,938 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.48M.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Quarry LP's portfolio in Q2 2026, its #200 holding.
  • Quarry LP first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and has held it in 5 quarters since.
  • Quarry LP's State Street SPDR S&P Biotech ETF position peaked at $2.95M in Q3 2025.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.